polymorphism of il-28b gene (rs12979860) in hcv genotype 1 patients treated by pegylated interferon and ribavirin

Authors

fahimeh safarnezhad tameshkel

gastrointestinal & liver disease research center (gildrc), iran university of medical sciences, tehran, iran mohmmad hadi karbalaie niya

dept. of virology, iran university of medical sciences, tehran, iran masuodreza sohrabi

gastrointestinal & liver disease research center (gildrc), iran university of medical sciences, tehran, iran mahshid panahi

gastrointestinal & liver disease research center (gildrc), iran university of medical sciences, tehran, iran farhad zamani

abstract

background: nowadays, the immune response to hepatitis c (hcv) treatment has become a crucial issue mostly due to the interleukin 28b (il-28b) polymorphism effects in chronic hcv patients. the aim of this study was to detect the polymorphism of il-28b gene (rs12979860) in hcv genotype 1 patients treated with pegylated interferon and ribavirin. methods: from the 2010 to 2012, a total of 115 peripheral blood mononuclear cells (pbmcs) of hcv patients who presented to gastrointestinal & liver disease research center (gildrc), firoozgar hospital, tehran, iran were enrolled in this retrospective cross sectional study. samples were then categorized based on the presence of sustained virologic response (svr and no-svr). variables including age, gender, serum alanine aminotransferase (alt) and aspartate aminotransferase (ast) levels of the two groups were investigated based on different il-28b genotypes. results: analysis by the variables of age and gender showed a mean age ± sd of 42.1±14.0 and gender variability of 44 females (38.2%) and 71 males (61.8%). adding up these results, the analysis of alt levels revealed that there was between 293 and 14 mg/ml; ast levels ranged between 217 and 17 mg/ml; the viral load (hcv rna) ranged between 7,822,000 and 50 iu/ml; the prevalence of cc, ct and tt genotypes were 90.9%, 54% and 25.0%. conclusion: il-28b polymorphism has an effective impact on the therapeutic response to ribavirin and peginterferon combination therapy in chronic hcv patients infected by different genotypes. this polymorphism is crucial in natural clearance.   how to cite this article: safarnezhad tameshkel f, karbalaie niya mh, sohrabi m, panahi m, zamani f, imanzade f, et al. polymorphism of il-28b gene (rs12979860) in hcv genotype 1 patients treated by pegylated interferon and ribavirin. iran j pathol. 2016; 11(3):216-21.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1 Patients Treated by Pegylated Interferon and Ribavirin

Background: Nowadays, the immune response to hepatitis C (HCV) treatment has become a crucial issue mostly due to the interleukin 28B (IL-28B) polymorphism effects in chronic HCV patients. The aim of this study was to detect the polymorphism of IL-28B gene (rs12979860) in HCV genotype 1 patients treated with pegylated Interferon and Ribavirin. Methods...

full text

Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and Ribavirin.

BACKGROUND Nowadays, the immune response to hepatitis C (HCV) treatment has become a crucial issue mostly due to the interleukin 28B (IL-28B) polymorphism effects in chronic HCV patients. The aim of this study was to detect the polymorphism of IL-28B gene (rs12979860) in HCV genotype 1 patients treated with pegylated Interferon and Ribavirin. METHODS From the 2010 to 2012, a total of 115 peri...

full text

High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).

BACKGROUND & AIMS In patients with chronic hepatitis C who failed to respond to standard therapy, high-dose pegylated interferon (IFN)-α and/or ribavirin could induce a stronger antiviral response and prevent treatment failure and HCV resistance when combined with direct-acting antivirals. The influence of genetic determinants in this context remains unknown. METHODS Eighty-three patients inf...

full text

Studying the Frequency of Favorable Allele of rs12979860 Polymorphism of IL-28B in Healthy and HCV Infected Iranian Individuals

Background & Objective: Hepatitis C Virus (HCV) is one of the important risk factors for liver cirrhosis and hepatocellular carcinoma. Some of the host genetic factors such as interleukin 28B (IL-28B) may influence the response to the antiviral therapy. IL28B is a member of the interferon (IFN) family which causes an antiviral response. Previous studies indicated that rs12979860 polymorphisms o...

full text

The Role of Interleukin-28b Gene Polymorphisms in Chinese Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin

BACKGROUND Interleukin-28B (IL28B) single nucleotide polymorphism (SNP) rs8099917 has been described to be associated with response to treatment with pegylated interferon and ribavirin (PEG-IFN/RBV) in patients with chronic hepatitis C from the North America, Europe, Asia countries like Japan and Taiwan. Whether this holds true for Chinese patients remains unknown. OBJECTIVES We aimed to stud...

full text

بر IL 28B ژن rs اثر پلی مورفیسم تک نوکلئوتیدی 12979860 پاسخ به درمان با پگ- اینترفرون/ریباورین در بیماران C ایرانی مبتلا به هپاتیت

Background and purpose: The standard of care treatment for infected patients with HCV is based on a combination of pegylated interferon alpha and ribavirin. Recently, the rs12979860 SNP polymorphism, located upstream of the interleukin 28B gene, was shown to be strongly associated with response to anti-HCV therapy. This study investigated the distribution of the (C/T) polymorphism with sust...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pathology

جلد ۱۱، شماره ۳، صفحات ۲۱۶-۲۲۱

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023